During the past decade, Viking Clinical Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 18 clinical trials were completed, i.e. on average, 105.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Viking Clinical Research" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 6 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Cephalon" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Viking Clinical Research" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Sunovion" with 1 trials as a collaborator, "University of Michigan" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Viking Clinical Research" are "Depressive Disorder, Major" (9 trials), "Depression" (3 trials), "Major Depressive Disorder" (3 trials), "Borderline Personality Disorder" (2 trials) and "Major Depressive Disorder (MDD)" (2 trials). Many other conditions were trialed in "Viking Clinical Research" in a lesser frequency.

Most popular intervention types in "Viking Clinical Research" are "Drug" (28 trials), "Other" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Rapastinel" (6 trials), "placebo" (3 trials), "Armodafinil" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Viking Clinical Research" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Viking Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Viking Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Viking Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".